Silk Historical Income Statement
| SILK Stock | USD 18.90 1.10 6.18% |
Historical analysis of Silk Road income statement accounts such as Selling General Administrative of 86.4 M, Total Revenue of 95 M, Gross Profit of 68.8 M or Other Operating Expenses of 137.4 M can show how well Silk Road Medical performed in making a profits. Evaluating Silk Road income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Silk Road's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Silk Road Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Silk Road Medical is a good buy for the upcoming year.
Silk |
About Silk Income Statement Analysis
Silk Road Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Silk Road shareholders. The income statement also shows Silk investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Silk Road Income Statement Chart
Silk Road Medical Income Statement is one of the three primary financial statements used for reporting Silk's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Silk Road Medical revenue and expense. Silk Road Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Silk Road's Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 10.5 M this year, although the value of Total Revenue will most likely fall to about 95 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Silk Road Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Silk Road Medical minus its cost of goods sold. It is profit before Silk Road operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Silk Road Medical. It is also known as Silk Road overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Silk Road's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Silk Road Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silk Road Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Silk Road's Net Interest Income is quite stable compared to the past year. Interest Income is expected to rise to about 10.5 M this year, although the value of Total Revenue will most likely fall to about 95 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 175K | 2.3M | 3.8M | 4.0M | Interest Income | 198K | 2.5M | 10.0M | 10.5M |
Silk Road income statement Correlations
Click cells to compare fundamentals
Silk Road Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Silk Road income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | (3.3M) | (3.3M) | (2.3M) | (2.6M) | 3.1M | 3.2M | |
| Interest Income | 1.7M | 1.1M | 198K | 2.5M | 10.0M | 10.5M | |
| Depreciation And Amortization | 1.7M | 1.1M | 175K | 2.3M | 3.8M | 4.0M | |
| Interest Expense | 5.0M | 4.4M | 2.5M | 5.1M | 6.9M | 5.1M | |
| Selling General Administrative | 62.9M | 75.3M | 96.2M | 116.0M | 144.6M | 86.4M | |
| Total Revenue | 63.4M | 75.2M | 101.5M | 138.6M | 177.1M | 95.0M | |
| Gross Profit | 47.4M | 53.9M | 76.0M | 100.8M | 127.1M | 68.8M | |
| Other Operating Expenses | 91.4M | 118.1M | 148.9M | 190.6M | 236.4M | 137.4M | |
| Operating Income | (28.1M) | (42.9M) | (47.5M) | (52.0M) | (59.3M) | (62.2M) | |
| Net Income From Continuing Ops | (52.4M) | (47.4M) | (49.8M) | (55.0M) | (55.7M) | (58.5M) | |
| Ebit | (28.1M) | (42.9M) | (47.5M) | (52.0M) | (59.3M) | (62.2M) | |
| Research Development | 12.3M | 21.3M | 27.1M | 36.4M | 41.3M | 24.5M | |
| Ebitda | (26.4M) | (41.8M) | (47.3M) | (49.7M) | (55.5M) | (58.3M) | |
| Cost Of Revenue | 15.9M | 21.3M | 25.4M | 37.9M | 50.0M | 26.2M | |
| Total Operating Expenses | 75.5M | 96.8M | 123.5M | 152.8M | 186.4M | 111.2M | |
| Reconciled Depreciation | 1.3M | 1.4M | 1.9M | 3.2M | 3.8M | 1.9M | |
| Income Before Tax | (52.4M) | (47.4M) | (49.8M) | (55.0M) | (55.7M) | (58.5M) | |
| Total Other Income Expense Net | (24.4M) | (4.5M) | (2.3M) | (3.0M) | 3.5M | 3.7M | |
| Net Income Applicable To Common Shares | (52.4M) | (47.4M) | (49.8M) | (55.0M) | (49.5M) | (52.0M) | |
| Net Income | (56.1M) | (50.4M) | (50.4M) | (58.0M) | (55.7M) | (58.5M) | |
| Income Tax Expense | 3.7M | 3.0M | 576K | 3.0M | 43K | 40.9K |
Currently Active Assets on Macroaxis
When determining whether Silk Road Medical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Silk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Silk Road Medical Stock. Highlighted below are key reports to facilitate an investment decision about Silk Road Medical Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silk Road Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Silk Stock analysis
When running Silk Road's price analysis, check to measure Silk Road's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silk Road is operating at the current time. Most of Silk Road's value examination focuses on studying past and present price action to predict the probability of Silk Road's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silk Road's price. Additionally, you may evaluate how the addition of Silk Road to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Silk Road's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silk Road. If investors know Silk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silk Road listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Revenue Per Share 4.565 | Quarterly Revenue Growth 0.18 | Return On Assets (0.14) | Return On Equity (0.35) |
The market value of Silk Road Medical is measured differently than its book value, which is the value of Silk that is recorded on the company's balance sheet. Investors also form their own opinion of Silk Road's value that differs from its market value or its book value, called intrinsic value, which is Silk Road's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silk Road's market value can be influenced by many factors that don't directly affect Silk Road's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silk Road's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silk Road is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silk Road's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.